AVDL — AVADEL PHARMACEUTICALS PLC

Ownership history in ALGERT GLOBAL LLC  ·  2 quarters on record

This page tracks every 13F SEC filing in which ALGERT GLOBAL LLC reported a position in AVADEL PHARMACEUTICALS PLC (AVDL). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.05% (2025 Q3)
Avg. % of fund
0.03%
First filed
2023 Q4
Last filed
2025 Q3
Quarters held
2
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 182,590 +167,140 +1081.8% 0.05% $2.8M $15.27
2023 Q4 INITIATED 15,450 — — 0.01% $218K —
% of Fund (quarterly)    AVDL price (monthly, adj. close)

Other funds also holding AVDL

As of 2025 Q4 — sorted by position size

WEALTH EFFECTS LLC 3Y 12.75% Krensavage Asset Management, LLC 3Y 7Y 6.51% Knoll Capital Management, LLC 3Y 7Y 5.93% KOTLER KEVIN 4.43% EQUITEC PROPRIETARY MARKETS, LLC 3Y 7Y 4.26% TIG Advisors, LLC 3Y 7Y 3.85% Vivo Capital, LLC 3Y 7Y 3.74% KOTLER KEVIN 3.74% WATER ISLAND CAPITAL LLC 3Y 7Y 2.53% HARVEST MANAGEMENT LLC 3Y 7Y 2.07%
← Back to ALGERT GLOBAL LLC Holdings